Osborn Williams & Donohoe’s Adient ADNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-53
Closed -$1K 320
2019
Q1
$1K Buy
+53
New +$928 ﹤0.01% 736
2018
Q2
Sell
-3,730
Closed -$223K 226
2018
Q1
$223K Sell
3,730
-1,092
-23% -$72.8K 0.04% 209
2017
Q4
$379K Sell
4,822
-300
-6% -$24.2K 0.06% 176
2017
Q3
$430K Sell
5,122
-702
-12% -$49.8K 0.08% 166
2017
Q2
$381K Sell
5,824
-2,295
-28% -$156K 0.07% 171
2017
Q1
$590K Sell
8,119
-1,802
-18% -$118K 0.11% 148
2016
Q4
$582K Buy
+9,921
New +$524K 0.11% 148

Other funds holding ADNT

Osborn Williams & Donohoe's ADNT Position: Q2 2019 in Review

Osborn Williams & Donohoe sold out of Adient (ADNT) in Q2 2019, closing a stake of 53 shares — an estimated $1K sold.

Osborn Williams & Donohoe first reported a position in ADNT in Q4 2016 and held it in 7 quarters. The position peaked at $590K in Q1 2017. 314 funds tracked by Wall St. Rank hold ADNT as of Q2 2019.

  • Osborn Williams & Donohoe reported no remaining Adient position as of Q2 2019 after selling out during the quarter.
  • Osborn Williams & Donohoe sold 53 Adient shares in Q2 2019, an estimated $1K.
  • Osborn Williams & Donohoe first reported a position in Adient in Q4 2016 and held it in 7 quarters.
  • Osborn Williams & Donohoe's Adient position peaked at $590K in Q1 2017.
  • 314 funds tracked by Wall St. Rank held Adient as of Q2 2019.

Based on Osborn Williams & Donohoe's 13F filing for Q2 2019, filed 26 Jul 2019.